PRESS RELEASE
8 September 2025

Goodmans Once Again Honoured At LMG Life Sciences Americas Awards 2025

GL
Goodmans LLP

Contributor

Goodmans is internationally recognized as one of Canada’s pre-eminent business law firms. Based in Toronto, the firm has market-leading expertise in M&A, corporate and transaction finance, private equity, real estate, tax, restructuring, litigation, intellectual property and other business-related specialties.
We are proud to share the Goodmans Intellectual Property Litigation team has been awarded at the LMG Life Sciences Americas Awards 2025 for the second year in a row!
Canada

We are proud to share the Goodmans Intellectual Property Litigation team has been awarded at the LMG Life Sciences Americas Awards 2025 for the second year in a row!

Patent Impact Case of the Year - Takeda Canada v Apotex (2024 FC 106)

Goodmans successfully represented Apotex Inc., with a trial team comprised of Andrew Brodkin, Jenene Roberts, Jaclyn Tilak, Jerry Topolski and Emily Groper, in which they avoided a finding of patent infringement sought by Takeda relating to dexlansoprazole products. This is the team's second impact case of the year award in 2025.

About LMG Life Sciences Americas Awards

The LMG Life Sciences Americas Awards recognize the region's most distinguished practitioners and their firms for their exemplary work in the Life Sciences legal practice over the past twelve months. After months of research and submission reviews, the LMG Life Sciences team set out to uncover the most impactful cases, deals, and the lawyers and law firms behind them.

To learn more, visit the LMG Life Sciences website here.

Contributor

Goodmans is internationally recognized as one of Canada’s pre-eminent business law firms. Based in Toronto, the firm has market-leading expertise in M&A, corporate and transaction finance, private equity, real estate, tax, restructuring, litigation, intellectual property and other business-related specialties.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More